Sandoz announces agreement to acquire leading antifungal agent Mycamine from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio Read more
Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso Read more
Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi Arabia Read more
Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase Inhibitor Read more
BioCryst Selects Swixx BioPharma as Commercial Partner for ORLADEYO (berotralstat) in Central and Eastern Europe Read more
TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors Read more
Blueprint Medicines Announces FDA Acceptance of Supplemental New Drug Application for AYVAKIT (avapritinib) for the Treatment of Indolent Systemic Mastocytosis Read more